Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Doehn
D Jocham

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: Abarelix, Praecis pharmaceuticalsC Doehn, D Jocham
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|August 3, 2004
Vaccination immunotherapy--an updateC Doehn, D Jocham
Der Urologe. Ausg. A|September 7, 2002
[Obstruction of the lower urinary tract]D Jocham, C Doehn
Onkologie|November 8, 2003
[Quality of life in urologic oncology: new aspects]C Doehn, D Jocham
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: TG-1031, Transgene SAC Doehn, D Jocham
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: CN-706, Calydon IncC Doehn, D Jocham
Current Opinion in Molecular Therapeutics|May 8, 2001
Technology evaluation: CV-787, Calydon IncC Doehn, D Jocham
Aktuelle Urologie|May 18, 2004
[Immunotherapy of renal cell carcinoma: results from current phase-III-trials]C Doehn, D Jocham
The Journal of Urology|October 23, 1997
Laparoscopic nephropexy: 3-year experienceP Fornara, C Doehn, D Jocham
International Journal of Urology : Official Journal of the Japanese Urological Association|June 22, 1999
Intra-abdominal abscess due to patient non-compliance after construction of an ileal neobladder: case report and review of the literatureC Doehn, A Böhle, D Jocham
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: Abarelix, Praecis pharmaceuticalsC Doehn, D Jocham
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|August 3, 2004
Vaccination immunotherapy--an updateC Doehn, D Jocham
Der Urologe. Ausg. A|September 7, 2002
[Obstruction of the lower urinary tract]D Jocham, C Doehn
Onkologie|November 8, 2003
[Quality of life in urologic oncology: new aspects]C Doehn, D Jocham
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: TG-1031, Transgene SAC Doehn, D Jocham
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: CN-706, Calydon IncC Doehn, D Jocham
Current Opinion in Molecular Therapeutics|May 8, 2001
Technology evaluation: CV-787, Calydon IncC Doehn, D Jocham
Aktuelle Urologie|May 18, 2004
[Immunotherapy of renal cell carcinoma: results from current phase-III-trials]C Doehn, D Jocham
The Journal of Urology|October 23, 1997
Laparoscopic nephropexy: 3-year experienceP Fornara, C Doehn, D Jocham
International Journal of Urology : Official Journal of the Japanese Urological Association|June 22, 1999
Intra-abdominal abscess due to patient non-compliance after construction of an ileal neobladder: case report and review of the literatureC Doehn, A Böhle, D Jocham
Pageof 20